Skip to main content

Find Clinical Trials

Home
Conditions
Esophageal Squamous Cell Carcinoma

Clinical trial condition

Esophageal Squamous Cell Carcinoma

Explore clinical trials studying Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

418 public trials 137 recruiting studies

Refine in advanced search Browse all conditions

Esophageal Squamous Cell Carcinoma trial results

Completed

Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

NCT00022139

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +17 more
Locations: Cancer Center of Kansas, PA - Chanute Chanute, Kansas, United States

Cancer Center of Kansas, PA - Dodge City Dodge City, Kansas, United States

Cancer Center of Kansas, PA - El Dorado El Dorado, Kansas, United States

Cancer Center of Kansas, PA - Kingman Kingman, Kansas, United States

View all 35 locations

View Trial Details

Completed

A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus

NCT01608022

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Severance hospital Seoul, South Korea

View Trial Details

Completed

Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

NCT00003118

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations: University of California San Diego Cancer Center La Jolla, California, United States

UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States

CCOP - Christiana Care Health Services Wilmington, Delaware, United States

Walter Reed Army Medical Center Washington D.C., District of Columbia, United States

View all 38 locations

View Trial Details

Completed

Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy

NCT01129206

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of the Esophagus, +19 more
Locations: Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery

NCT00544362

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations: Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besançon, France

Hopital Saint Andre Bordeaux, France

C.H.U. de Brest Brest, France

CHR Clermont Ferrand, Hotel Dieu Clermont-Ferrand, France

View all 13 locations

View Trial Details

Completed

Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer

NCT00524121

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study

NCT01854749

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Cancer hospital Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Completed

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

NCT00900302

Conditions: Anus Diseases, Anus Neoplasms, Biliary Tract Diseases, +77 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer

NCT00268346

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell Carcinoma

NCT01474642

Conditions: Advanced or Recurrent Esophageal Squamous Cell Carcinoma, Carcinoma, Carcinoma, Squamous Cell, +13 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details